Evoq Remedies (BOM:543500) Cash-to-Debt : 0.04 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Evoq Remedies's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.04.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Evoq Remedies couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Evoq Remedies's Cash-to-Debt or its related term are showing as below:

BOM:543500' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.37 Max: 27.75
Current: 0.04

During the past 5 years, Evoq Remedies's highest Cash to Debt Ratio was 27.75. The lowest was 0.00. And the median was 0.37.

BOM:543500's Cash-to-Debt is ranked worse than
95.83% of 96 companies
in the Medical Distribution industry
Industry Median: 0.79 vs BOM:543500: 0.04

Evoq Remedies Cash-to-Debt Historical Data

The historical data trend for Evoq Remedies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Evoq Remedies Cash-to-Debt Chart

Evoq Remedies Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Cash-to-Debt

15.67

0.37

27.75

0.38

0.02

Evoq Remedies Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial			N/A	0.38	-	0.02	0.04

Competitive Comparison of Evoq Remedies's Cash-to-Debt

For the Medical Distribution subindustry, Evoq Remedies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoq Remedies's Cash-to-Debt Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's Cash-to-Debt falls into.

Evoq Remedies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Evoq Remedies's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.536	/	(95.762	+	0)
	=	0.02

Evoq Remedies's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.567	/	(12.759	+	0)
	=	0.04

Evoq Remedies (BOM:543500) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Evoq Remedies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines